← Open Payments lookup

PILAR ARABIA: Open Payments

NPI 1669665097 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,916 in 89 payments from 13 companies in 2025. Trend: 2023 $767 · 2024 $482 · 2025 $1,916

Food & beverage: $1,916
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.25$371
Janssen Pharmaceuticals, Inc9$340
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$263
Alkermes, Inc.8$224
E.R. Squibb & Sons, L.L.C.13$193
ABBVIE INC.5$186
Neurocrine BioSciences, Inc.7$162
ACADIA Pharmaceuticals Inc2$38
Axsome Therapeutics, Inc.2$36
Eisai Inc.1$29

Products named: REXULTI, CAPLYTA, ARISTADA, SPRAVATO, COBENFY, INGREZZA, VRAYLAR, INVEGA SUSTENNA.

Industry payments across NV — which companies pay providers there.